TERAPEUTICA. I: O TRATAMENTO FARMACOLOLICO DAS DEPRESSOES = THERAPEUTIQUES: CHIMIOTHERAPIE DES DEPRESSIONSVERSIANI M.1979; J. BRAS. PSIQUIATR.; BRA; DA. 1979; VOL. 28; NO 1-4; PP. 17-22; ABS. ENG; BIBL. 28 REF.Article

TERAPEUTICA. III: ANTIPSICOTICOS, PRINCIPIOS GERAIS = THERAPEUTIQUE III: ANTIPSYCHOTIQUES, PRINCIPES GENERAUXVERSIANI M.1980; J. BRAS. PSIQUIATR.; BRA; DA. 1980; VOL. 29; NO 2; PP. 87-90; ABS. ENG; BIBL. 4 REF.Article

INCONGRUENCIAS NA ATUAL ABORDAGEM DO ABUSO DE DROGAS = CONTRADICTIONS ET ILLOGISMES DANS LES RECHERCHES ACTUELLES SUR LA TOXICOMANIEVERSIANI M.1980; J. BRAS. PSIQUIATR.; ISSN 0047-2085; BRA; DA. 1980; VOL. 29; NO 6; PP. 379-383; ABS. ENG; BIBL. 3 REF.Article

A DOUBLE-BLIND COMPARISON BETWEEN LOXAPINE AND HALOPERIDOL BY PARENTERAL ROUTE IN ACUTE SCHIZOPHRENIA.PAPROCKI J; VERSIANI M.1977; CURR. THERAPEUT. RES.; U.S.A.; DA. 1977; VOL. 21; NO 1; PP. 80-100; BIBL. 1 P. 1/2Article

LOXAPINE VERSUS THIORIDAZINE IN THE TREATMENT OF ORGANIC PSYCHOSISVERSIANI M; DA SILVA JAR; MUNDIM FD et al.1980; J. INTERNATION. MED. RES.; GBR; DA. 1980; VOL. 8; NO 1; PP. 22-30; BIBL. 8 REF.Article

Pharmacotherapy of dysthymic and chronic depressive disorders : overview with focus on moclobemideVERSIANI, M.Journal of affective disorders. 1998, Vol 51, Num 3, pp 323-332, issn 0165-0327Article

A DOUBLE-BLIND COMPARISON BETWEEN LOXAPINE AND CHLORDIAZEPOXIDE IN THE TREATMENT OF NEUROTIC ANXIETY.VERSIANI M; BUENO JR; MUNDIM FD et al.1976; CURR. THERAPEUT. RES.; U.S.A.; DA. 1976; VOL. 20; NO 5; PP. 701-715; BIBL. 8 REF.Article

Dysthymia : Review - new findings - treatment guidelinesVERSIANI, M; NARDI, A. E; FIGUEIRA, I et al.Psiquiatria biológica (Belo Horizonte). 1997, Vol 5, Num 2, pp 75-83, issn 0104-7787Article

Double-blind, placebo-controlled study with reboxetine in inpatients with severe major depressive disorderVERSIANI, M; AMIN, M; CHOUINARD, G et al.Journal of clinical psychopharmacology. 2000, Vol 20, Num 1, pp 28-34, issn 0271-0749Article

Social phobia : long-term treatment outcome and prediction of response : a moclobemide studyVERSIANI, M; AMREIN, R; MONTGOMERY, S. A et al.International clinical psychopharmacology. 1997, Vol 12, Num 5, pp 239-254, issn 0268-1315Article

Pharmacotherapy of dysthymia : review and new findingsVERSIANI, M; NARDI, A. E; FIGUEIRA, I et al.European psychiatry. 1998, Vol 13, Num 4, pp 203-209, issn 0924-9338Article

Reboxetine, a unique selective NRI, prevents relapse and recurrence in long-term treatment of major depressive disorderVERSIANI, M; MEHILANE, L; GASZNER, P et al.The Journal of clinical psychiatry. 1999, Vol 60, Num 6, pp 400-406, issn 0160-6689Article

L'amineptine dans le traitement des dépressions: étude multicentrique brésilienne = Amineptin in the treatment of depression: a brazilian multicenter studyCOSTA E SILVA, J. A; VERSIANI, M; RUSKEN, S et al.Journal de psychiatrie biologique et thérapeutique. 1984, pp 32-35, issn 0292-2509, no spécArticle

Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trialKATONA, C; BERCOFF, E; CHIU, E et al.Journal of affective disorders. 1999, Vol 55, Num 2-3, pp 203-213, issn 0165-0327Article

Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placeboVERSIANI, M; NARDI, A. E; FIGUEIRA, I. L. V et al.Acta psychiatrica scandinavica. Supplementum. 1990, Vol 82, Num 360, pp 24-28, issn 0065-1591, 5 p.Conference Paper

The man with the purple nostrils: a case of rhinotrichotillomania secondary to body dysmorphic disorder. CommentaryFONTENELLE, L. F; MENDLOWICZ, M. V; MUSSI, T. C et al.Acta psychiatrica Scandinavica. 2002, Vol 106, Num 6, pp 464-466, issn 0001-690X, 3 p.Article

Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression) : a double-blind comparisonVERSIANI, M; ONTIVEROS, A; MAZZOTTI, G et al.International clinical psychopharmacology. 1999, Vol 14, Num 6, pp 321-327, issn 0268-1315Article

A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)DAVIDSON, J. R; ZHANG, W; STEIN, D. J et al.Journal of psychopharmacology (Oxford). 2010, Vol 24, Num 1, pp 3-26, issn 0269-8811, 24 p.Article